Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T10:04:52.000Z Has data issue: false hasContentIssue false
  • English
  • Français

SSRIs and tricyclic antidepressants

Published online by Cambridge University Press:  02 January 2018

L. J. Ashworth  and
K. C. M. Wilson
L. J. Ashworth
Affiliation:
The University of Liverpool Department of Psychiatry P.O. Box 147 Liverpool L69 3BX
K. C. M. Wilson
Affiliation:
The University of Liverpool Department of Psychiatry P.O. Box 147 Liverpool L69 3BX
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 162 , Issue 3 , March 1993 , pp. 426
Copyright
Copyright © The Royal College of Psychiatrists 

References

Brosen, K., et al (1992) Pharmacogenetics of tricyclic antidepressants and novel antidepressants: recent developments. Clinical Neuropharmacology, 15, 80A—81A.Google Scholar
Brosen, K. & Skelbo, E. (1990) Fluoxetine and norfluoxetine are potent inhibitors of P450—II—D6 — the source of the sparteine/debrisoquine oxidation polymorphism. British Journal of Clinical Pharmacology, 32, 136—137.Google Scholar
Committee on Safety of Medicines (1989) Current Problems (May).Google Scholar
Preskorn, S. H. & Fast, G. A. (1991) Therapeutic drug monitoring for antidepressants: efficacy, safety and cost effectiveness. Journal of Clinical Psychiatry, 52, 23—33.Google Scholar
van Ameringen, M. & Mancini, C. (1992) Adverse effects of switching from fluoxetine to desipramine. Canadian Journal of Psychiatry, 37, 278.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.